France's Sanofi to buy biotech firm Synthorx for $2.5 billion
December 09, 2019 at 03:12 AM EST
Sanofi said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker's pipeline of drugs for cancer and auto-immune disorders.